Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men

W. J. Maierhofer, J. Lemann, R. W. Gray, Herman S Cheung

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We previously reported that experimental elevations of serum 1,25-(OH)2-vitamin D [1,25-(OH)2-D] concentrations produced by the chronic oral administration of calcitriol, 0.75 μg every 6 hr, to healthy human males eating diets providing only 4 mmoles Ca/day stimulate net bone resorption as evidence by more negative Ca balances and higher rates of urinary hydroxyproline excretion. To determine whether increased dietary Ca intake modified this response we have compared serum 1,25-(OH)2-D and iPTH concentrations, Ca and PO4 balances, and urinary hydroxyproline excretion in three healthy human males adapted to diets providing 22.3 ± 1.3 mmoles Ca/day and three healthy human males adapted to diets providing 9.3 ± 0.7 mmoles Ca/day before and during the continuous oral administration of calcitriol 0.5 μg every 6 hr. For all six subjects, serum 1,25-(OH)2-D levels averaged 89 ± 25 PM during control and 143 ± 26 PM during calcitriol. Net intestinal Ca absorption and urinary Ca excretion rose during calcitriol but Ca balances did not change, averaging +2.2 ± 2.2 mmoles/day during control and +4.3 ± 2.2 mmoles/day during calcitriol for the subjects fed 22 mmoles Ca/day and -1.6 ± 1.5 mmoles Ca/day during control and -1.7 ± 2.0 mmoles Ca/day during calcitriol for the subjects fed 9 mmoles Ca/day. Urinary hydroxyproline excretion also did not change. Thus, when serum 1,25-(OH)2-D levels are elevated, the availability of dietary Ca appears to prevent more negative Ca balances and increased urinary hydroxyproline excretion suggesting that net bone resorption is not stimulated.

Original languageEnglish
Pages (from-to)752-759
Number of pages8
JournalKidney International
Volume26
Issue number5
StatePublished - Dec 1 1984
Externally publishedYes

Fingerprint

Ergocalciferols
Dietary Calcium
Calcitriol
Hydroxyproline
Calcium
Serum
Bone Resorption
Diet
Oral Administration
Intestinal Absorption
Eating

ASJC Scopus subject areas

  • Nephrology

Cite this

Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men. / Maierhofer, W. J.; Lemann, J.; Gray, R. W.; Cheung, Herman S.

In: Kidney International, Vol. 26, No. 5, 01.12.1984, p. 752-759.

Research output: Contribution to journalArticle

@article{f1f83799ed244597ac35df9b54d30408,
title = "Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men",
abstract = "We previously reported that experimental elevations of serum 1,25-(OH)2-vitamin D [1,25-(OH)2-D] concentrations produced by the chronic oral administration of calcitriol, 0.75 μg every 6 hr, to healthy human males eating diets providing only 4 mmoles Ca/day stimulate net bone resorption as evidence by more negative Ca balances and higher rates of urinary hydroxyproline excretion. To determine whether increased dietary Ca intake modified this response we have compared serum 1,25-(OH)2-D and iPTH concentrations, Ca and PO4 balances, and urinary hydroxyproline excretion in three healthy human males adapted to diets providing 22.3 ± 1.3 mmoles Ca/day and three healthy human males adapted to diets providing 9.3 ± 0.7 mmoles Ca/day before and during the continuous oral administration of calcitriol 0.5 μg every 6 hr. For all six subjects, serum 1,25-(OH)2-D levels averaged 89 ± 25 PM during control and 143 ± 26 PM during calcitriol. Net intestinal Ca absorption and urinary Ca excretion rose during calcitriol but Ca balances did not change, averaging +2.2 ± 2.2 mmoles/day during control and +4.3 ± 2.2 mmoles/day during calcitriol for the subjects fed 22 mmoles Ca/day and -1.6 ± 1.5 mmoles Ca/day during control and -1.7 ± 2.0 mmoles Ca/day during calcitriol for the subjects fed 9 mmoles Ca/day. Urinary hydroxyproline excretion also did not change. Thus, when serum 1,25-(OH)2-D levels are elevated, the availability of dietary Ca appears to prevent more negative Ca balances and increased urinary hydroxyproline excretion suggesting that net bone resorption is not stimulated.",
author = "Maierhofer, {W. J.} and J. Lemann and Gray, {R. W.} and Cheung, {Herman S}",
year = "1984",
month = "12",
day = "1",
language = "English",
volume = "26",
pages = "752--759",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men

AU - Maierhofer, W. J.

AU - Lemann, J.

AU - Gray, R. W.

AU - Cheung, Herman S

PY - 1984/12/1

Y1 - 1984/12/1

N2 - We previously reported that experimental elevations of serum 1,25-(OH)2-vitamin D [1,25-(OH)2-D] concentrations produced by the chronic oral administration of calcitriol, 0.75 μg every 6 hr, to healthy human males eating diets providing only 4 mmoles Ca/day stimulate net bone resorption as evidence by more negative Ca balances and higher rates of urinary hydroxyproline excretion. To determine whether increased dietary Ca intake modified this response we have compared serum 1,25-(OH)2-D and iPTH concentrations, Ca and PO4 balances, and urinary hydroxyproline excretion in three healthy human males adapted to diets providing 22.3 ± 1.3 mmoles Ca/day and three healthy human males adapted to diets providing 9.3 ± 0.7 mmoles Ca/day before and during the continuous oral administration of calcitriol 0.5 μg every 6 hr. For all six subjects, serum 1,25-(OH)2-D levels averaged 89 ± 25 PM during control and 143 ± 26 PM during calcitriol. Net intestinal Ca absorption and urinary Ca excretion rose during calcitriol but Ca balances did not change, averaging +2.2 ± 2.2 mmoles/day during control and +4.3 ± 2.2 mmoles/day during calcitriol for the subjects fed 22 mmoles Ca/day and -1.6 ± 1.5 mmoles Ca/day during control and -1.7 ± 2.0 mmoles Ca/day during calcitriol for the subjects fed 9 mmoles Ca/day. Urinary hydroxyproline excretion also did not change. Thus, when serum 1,25-(OH)2-D levels are elevated, the availability of dietary Ca appears to prevent more negative Ca balances and increased urinary hydroxyproline excretion suggesting that net bone resorption is not stimulated.

AB - We previously reported that experimental elevations of serum 1,25-(OH)2-vitamin D [1,25-(OH)2-D] concentrations produced by the chronic oral administration of calcitriol, 0.75 μg every 6 hr, to healthy human males eating diets providing only 4 mmoles Ca/day stimulate net bone resorption as evidence by more negative Ca balances and higher rates of urinary hydroxyproline excretion. To determine whether increased dietary Ca intake modified this response we have compared serum 1,25-(OH)2-D and iPTH concentrations, Ca and PO4 balances, and urinary hydroxyproline excretion in three healthy human males adapted to diets providing 22.3 ± 1.3 mmoles Ca/day and three healthy human males adapted to diets providing 9.3 ± 0.7 mmoles Ca/day before and during the continuous oral administration of calcitriol 0.5 μg every 6 hr. For all six subjects, serum 1,25-(OH)2-D levels averaged 89 ± 25 PM during control and 143 ± 26 PM during calcitriol. Net intestinal Ca absorption and urinary Ca excretion rose during calcitriol but Ca balances did not change, averaging +2.2 ± 2.2 mmoles/day during control and +4.3 ± 2.2 mmoles/day during calcitriol for the subjects fed 22 mmoles Ca/day and -1.6 ± 1.5 mmoles Ca/day during control and -1.7 ± 2.0 mmoles Ca/day during calcitriol for the subjects fed 9 mmoles Ca/day. Urinary hydroxyproline excretion also did not change. Thus, when serum 1,25-(OH)2-D levels are elevated, the availability of dietary Ca appears to prevent more negative Ca balances and increased urinary hydroxyproline excretion suggesting that net bone resorption is not stimulated.

UR - http://www.scopus.com/inward/record.url?scp=0021751156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021751156&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 752

EP - 759

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -